Table of Contents

company-logo

Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for chronic autoimmune and inflammatory diseases using its proprietary Kinoid technology. The company's product pipeline includes IFNa Kinoid, an anti-interferon alpha vaccine that is in Phase IIb clinical trial for the treatment of systemic lupus erythematosus; Phase IIa clinical trial for the treatment of dermatomyositis; and preclinical stage for the treatment of diabetes. It is also developing VEGF-Kinoid, which is in preclinical stage for the treatment of age-related macular degeneration and solid tumors; and IL-4/IL-13 Kinoid that is in preclinical stage for the treatment of allergies. The company has a collaboration with the Sunnybrook Research Institute for preclinical development of VEGF Kinoid to treat colorectal and ovarian cancer. Neovacs S.A. was founded in 1993 and is based in Paris, France.

Neovacs Dividend Announcement

• Neovacs does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Neovacs dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Neovacs Dividend History

Neovacs Dividend Yield

Neovacs current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Neovacs stock? Use our calculator to estimate your expected dividend yield:

Neovacs Financial Ratios

P/E ratio-732.42
PEG ratio62.81
P/B ratio1908.21
ROE-123.46%
Payout ratio0.00%
Current ratio0.66
Quick ratio0.62
Cash Ratio0.05

Neovacs Dividend FAQ

Does Neovacs stock pay dividends?
Neovacs does not currently pay dividends to its shareholders.
Has Neovacs ever paid a dividend?
No, Neovacs has no a history of paying dividends to its shareholders. Neovacs is not known for its dividend payments.
Why doesn't Neovacs pay dividends?
There are several potential reasons why Neovacs would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Neovacs ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Neovacs has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Neovacs a dividend aristocrat?
Neovacs is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Neovacs a dividend king?
Neovacs is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Neovacs a dividend stock?
No, Neovacs is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Neovacs stocks?
To buy Neovacs you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Neovacs stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.